International Patent: SELF-INACTIVATING RETROVIRAL VECTOR FOR ENGINEERING MB-IL15-CA2 EXPRESSING TIL

GENEVA, Nov. 6 -- OBSIDIAN THERAPEUTICS, INC. filed a patent application (US2026/026213) for “SELF-INACTIVATING RETROVIRAL VECTOR FOR ENGINEERING MB-IL15-CA2 EXPRESSING TIL”. With publication no. WO/2026/232030, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/86

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....